Skip to content
Screener

Net margin at other companies

Amgen logo
AmgenAMGN
23%+4.0pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-928.4%-1,403pp
Schrodinger logo
SchrodingerSDGR
-68.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
121.5%+103pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759

FAQ

What is Septerna, Inc.'s net margin?
Septerna, Inc. (SEPN) reported net margin of -49.9% in Q1 2026.
How has Septerna, Inc.'s net margin changed year-over-year?
Septerna, Inc.'s net margin increased by 99.4% year-over-year, from -8,104.1% to -49.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Septerna, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude